Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole

Journal of the American Academy of Dermatology

Volumn 60, Issue 4, 2009, Pages 589-594

  Wanat, Karolyn A ^a   Anadkat, Milan J ^a   Klekotka, Paul A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBAMAZEPINE; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CORTICOSTEROID; COTRIMOXAZOLE; EFALIZUMAB; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; IMMUNOGLOBULIN; LAMOTRIGINE; LEVOFLOXACIN; METHYLPREDNISOLONE SODIUM SUCCINATE; NAPROXEN; OXCARBAZEPINE; PANTOPRAZOLE; PHENYTOIN; SULFADIAZINE; THALIDOMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEATH; FEMALE; GROUPS BY AGE; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL RECORD REVIEW; MORTALITY; PATIENT REFERRAL; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASONAL VARIATION; SKIN MANIFESTATION; SPRING; STEVENS JOHNSON SYNDROME; TERTIARY HEALTH CARE; TOXIC EPIDERMAL NECROLYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEASONS; STEVENS-JOHNSON SYNDROME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 61849156846     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.11.884     Document Type: Article

References (21)

1. Roujeau J.C., Kelly J.P., Naldi L., Rzany B., Stern R.S., Anderson T., et al. Medication use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis. N Engl J Med 333 (1995) 1600-1606
2. Bastuji-Garin S., Rzany B., Stern R.S., Shear N.H., Naldi L., and Roujeau J.C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129 (1993) 92-96
3. Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schröder W., and Roujeau J.C. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 138 (2002) 1019-1024
4. Rzany B., Hering O., Mockenhaupt M., Schröder W., Goerttler E., Ring J., et al. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 135 (1996) 6-11
5. Roujeau J.C., and Stern R.S. Severe cutaneous adverse reactions to drugs. N Engl J Med 331 (1994) 1272-1285
6. Halevy S., Ghislain P.D., Mockenhaupt M., Fagot J.P., Bouwes Bavinck J.N., Sidoroff A., et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58 (2008) 25-32
7. Mockenhaupt J., Viboud C., Dunant A., Naldi L., Halevy S., Bouwes Bavinck J.N., et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study. J Invest Dermatol 128 (2008) 35-44
8. Tay Y.K., Huff J.C., and Weston W.L. Mycoplasma pneumoniae infection is associated with Stevens Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol 35 (1996) 757-760
9. Mulvey J.M., Padowitz A., Lindley-Jones M., and Nickels R. Mycoplasma pneumoniae associated with Stevens-Johnson syndrome. Anaesth Intensive Care 35 (2007) 414-417
10. Leaute-Labreze C., Lamiereau T., Chawki D., Maleville J., and Taieb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 83 (2000) 347-352
11. Leigh I.M., Mowbray J.F., Levene G.M., and Sutherland S. Recurrent and continuous erythema multiforme-a clinical and immunological study. Clin Exp Dermatol 10 (1985) 58-67
12. Bastuji-Garin S., Fouchard N., Bertocchi M., Roujeau J.C., Revuz J., and Wolkenstein P. SCORTEN: a severity of illness score for toxic epidermal necrolysis. J Invest Dermatol 115 (2000) 149-153
13. U.S. Census Bureau, Annual Estimates of the Population. Available at: http://www.census.gov/population/www/estimates/CBSA-est2007-annual.html. Accessed June 2008.
14. Letko E., Papaliodis D.N., Papaliodis G.N., Daoud Y.J., Ahmed A.R., and Foster C.S. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol 94 (2005) 419-436
15. Denny F.W., and Civcle W.A. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis 123 (1971) 74-91
16. Luby J.P. Pneumonia caused by Mycoplasma pneumoniae infection. Clin Chest Med 12 (1991) 237-244
17. Lieberman D., Lieberman D., and Porath A. Seasonal variation in community acquired pneumonia. Eur Respir J 9 (1996) 2630-2634
18. Layani-Milon M.-P., Gras I., Valette M., Luciani J., Stagnara J., Aymard M., et al. Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods. J Clin Microbiol 37 (1999) 1721-1726
19. Scott D.A., Coulter W.A., and Lamey P.J. Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med 26 (1997) 441-447
20. Zawacki B.E., Azen S.P., Imbus S.H., and Chang Y.T.C. Multifactorial probit analysis of mortality in burned patients. Ann Surg 189 (1979) 1-5
21. Revuz J., Penso D., Roujeau J.C., Guillaume J.C., Payne C.R., Wechsler J., et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 123 (1987) 1160-1165